Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of SR-T100 Gel in Actinic Keratosis
NCT02559934Phase 1Completed
- Sponsor
- G&E Herbal Biotechnology
- Start
- Nov 2015
- Primary completion
- Jan 2019
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of SR-T100 in actinic keratosis (AK), sponsored by G&E Herbal Biotechnology. Primary endpoints: Area Under the Curve at Steady State at 16 weeks, Area Under the Moment Curve at Steady State at 16 weeks and 8 more. Started Nov 2015; status: completed.
02
Drugs
SR-T100
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02559934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02559934.